Traws Pharma, Inc.
TRAW · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $13,788 | $15,742 | $13,590 | $42,922 |
| - Cash | $21,338 | $20,821 | $38,757 | $55,070 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$7,550 | -$5,079 | -$25,167 | -$12,148 |
| Revenue | $226 | $226 | $226 | $226 |
| % Growth | 0% | 0% | 0% | – |
| Gross Profit | $214 | $226 | $226 | $226 |
| % Margin | 94.7% | 100% | 100% | 100% |
| EBITDA | -$166,511 | -$20,282 | -$19,613 | -$16,482 |
| % Margin | -73,677.4% | -8,974.3% | -8,678.3% | -7,292.9% |
| Net Income | -$54,674 | -$18,948 | -$18,964 | -$16,163 |
| % Margin | -24,192% | -8,384.1% | -8,391.2% | -7,151.8% |
| EPS Diluted | -35.21 | -22.569 | -22.675 | -24.006 |
| % Growth | -56% | 0.5% | 5.5% | – |
| Operating Cash Flow | -$29,792 | -$17,932 | -$16,294 | -$19,487 |
| Capital Expenditures | $0 | -$14 | $0 | $0 |
| Free Cash Flow | -$29,792 | -$17,946 | -$16,294 | -$19,487 |